A Guideline for the Management of Acute Upper Gastrointestinal Bleeding. Contents
|
|
- Leslie Briggs
- 7 years ago
- Views:
Transcription
1 A Guideline for the Management of Acute Upper Classification: Clinical Guideline Lead Author: Dr Abby Conlin, Clinical Director in Endoscopy Authors Division: Salford Health Care (Acute Medicine 2) Unique ID: 250TD(C)54 Issue number: 3 Expiry Date: June 2017 Contents Section Page Intro Who should read this document 2 Key practice points 2 Background/ Scope/ Definitions 3 What is new in this version 4 Policy/Procedure/Guideline 4-9 Flow Diagram Management of Non-variceal bleeding 10 Flow Diagram Management of Variceal Bleeding 11 Standards 12 References and Supporting Documents 12 Roles and Responsibilities 12 Document control information (Published as separate document) Document Control Policy Implementation Plan Monitoring and Review Endorsement Equality analysis Page 1 of 14
2 Who should read this document? All clinical staff involved in the management of patients presenting with acute upper GI bleeding. Specifically this includes doctors and nurses working in the Emergency Department, EAU, inpatient wards, critical care unit and theatres. Key Practice Points Resuscitate patients appropriately with care not to over transfuse. Risk assess every patient presenting with acute UGIB using Blatchford Score (GBS). Consider discharge in patients with acute UGIB and a GBS of 0 with planned early outpatient endoscopy. Acid-suppression drugs should not be offered to patients before endoscopy. Terlipressin and antibiotics should be given to all patients with suspected variceal acute UGIB (unless contraindicated). Unstable patients with GBS >5 should be offered endoscopy immediately after resuscitation. A surgical assessment forms a routine part of management planning in unstable patients with suspected non-variceal acute UGIB. Anaesthetic assessment is required in all patients where emergency endoscopy in theatres is planned. Patients who re-bleed after endoscopic treatment should be referred urgently for surgery. Interventional radiology is not immediately available at Salford Royal Hospital (see section 4.6.8). Page 2 of 14
3 Background/ Scope/ Definitions 1.0 Introduction and Objective: 1.1 Acute upper gastrointestinal bleeding (UGIB) is a common medical emergency with a 10% hospital mortality rate. The most common causes are peptic ulcer (non-variceal bleeding) and oesophago-gastric varices (variceal bleeding). Endoscopy is the primary diagnostic investigation and also allows treatments to be delivered that can stop bleeding or prevent re-bleeding. 1.2 The purpose of this document is to provide a framework for the management of acute UGIB and to ensure correct processes are followed. 1.3 This policy is applicable to all staff involved in managing patients with acute UGIB. 2.0 The Protocol Covers: 2.1 Patients with acute variceal and non-variceal upper gastrointestinal bleeding 2.2 Assessment of risk (including scoring system) 2.3 Initial patient management 2.4 Timing of endoscopy 2.4 Emergency endoscopy in theatres 3.0 The Policy Does Not Cover: 3.1 Lower gastrointestinal bleeding 3.2 Chronic gastrointestinal bleeding Page 3 of 14
4 What is new in this version? This version incorporates the NICE guidance on the management of acute upper gastrointestinal bleeding issued June The previous version of this policy was published in Clinical Guideline 4.1 Recognition of Acute Upper GI Bleeding Patients with acute UGIB can present with the following features; -haematemesis -melaena -coffee ground vomiting -anaemia -syncope -postural hypotension -shock Patients may present with anaemia, syncope, postural hypotension or shock in the absence of acute UGIB Features suggestive of acute UGIB caused by variceal bleeding include an established diagnosis of liver disease or clinical signs of undiagnosed liver disease (stigmata of chronic liver disease, serum markers of chronic liver disease) Features suggestive of a non-variceal cause for acute UGIB include previous non-variceal bleeding, anticoagulant/antiplatelet/nsaid use and no evidence of chronic liver disease It is recognised that non-variceal UGIB can occur in patients with established liver disease. However, patients presenting with acute UGIB bleed with a diagnosis of (or features suggestive of) chronic liver disease should be managed as a variceal bleed. Page 4 of 14
5 4.2 Risk Assessment All patients with suspected upper GI blood loss should have a formal risk assessment score using the Glasgow Blatchford Score (Table 1) Blatchford Score (GBS) should be documented in clinical notes and on endoscopy request forms. Table 1 Glasgow Blatchford Score Presenting Risk Marker Score Blood Urea 6.5 < < < Haemoglobin (g/l) for men 120 < <120 < Haemoglobin (g/l) for women 100 <120 < Systolic Blood Pressure (mmhg) < Other Markers Pulse 100/minute Presentation with melaena Presentation with syncope Chronic Liver Disease Cardiac Failure Page 5 of 14
6 4.2.3 Patients with a Blatchford Score of 0 should be considered for discharge from hospital with early outpatient endoscopy Unstable patients with GBS >5 (high risk bleed) should be discussed with a gastroenterology registrar, associate specialist or consultant Monday to Friday 9am-5pm and the on call endoscopist at any other time UGIB occurring in patients who have been in hospital for >24 hours should be discussed with a gastroenterology registrar, associate specialist or consultant. 4.3 Resuscitation and Initial Management Patients with massive bleeding should have blood, platelets and clotting factors in line with the hospital policy for massive blood loss Base decisions on blood transfusion on the full clinical picture, recognising that over-transfusion may be as damaging as undertransfusion. In general blood transfusion should be given if Hb is less than 70 g/l (aim for target Hb of g/l) Offer platelet transfusion only to patients who are actively bleeding and have a platelet count of less than 50 x 10 9 per litre Fresh frozen plasma should be offered in the following situations: -Fibrinogen level < 1g / litre -PT (INR) or APTT of > 1.5 times normal Offer prothrombin complex concentrate to patients who are taking Warfarin and actively bleeding Do not offer acid-suppression drugs (proton pump inhibitors or H2- receptor antagonists) before endoscopy to patients with UGIB All patients with suspected variceal blood loss should be given terlipressin (2mg every 4 hours, or reduce to 1mg after initial dose if not tolerated or body weight under 50kg) and antibiotics (as per hospital antibiotic policy). This should be administered no later than 4 hours after variceal bleeding is suspected and continued until the outcome of the endoscopy is known. Page 6 of 14
7 4.3.8 All patients with cirrhotic liver disease and non-variceal blood loss should continue to receive antibiotics after endoscopy Care should be taken with the volume of fluid used to resuscitate patients with variceal bleeding or cardiovascular comorbidity as overly aggressive resuscitation will have a negative impact on outcome In patients where there is concern of Terlipressin induced cardiac ischaemia, somatostatin or its analogue can be used. Somatostatin/ octreotide causes selective splanchnic vasoconstriction and reduces portal pressure and portal blood flow. Octreotide is given as an infusion of 25-50mcg/hour. Somatostatin is given as a 250mg intravenous bolus followed by an infusion of 250mg/hour. 4.4 Timing of Endoscopy (also see table 2) Unstable patients with GBS >5 (high risk bleed) should be offered endoscopy immediately after resuscitation All other patients with acute UGIB and a GBS 1 should be offered endoscopy within 24 hours Consider discharge in patients with acute UGIB and a GBS of 0 with planned early outpatient endoscopy If endoscopy is required outside 08:30am-5pm Monday to Friday and 08:30 am-12:30pm on Saturday, the endoscopic procedure will be carried out in emergency theatres by the on-call endoscopist Endoscopy is carried out for stable patients with acute upper GI bleeding in the endoscopy unit between the hours of 08:30 am-5pm Monday to Friday and 08:30am 12:30pm on Saturdays The endoscopy unit (extension or 65958) must be notified of stable patients with acute UGIB requiring endoscopy in GIU on Saturdays before 10:30am. Page 7 of 14
8 Table 2 Arranging Endoscopy contact information Mon-Fri 09:00-17:00 Mon-Fri 17:00-09:00 Sat 08:30-12:30 Sat 12:30-Mon 09:00 Stable Patients Send electronic referral and discuss with endoscopy Unit coordinator on ext or Send electronic referral and discuss with endoscopy Unit coordinator on ext or at 08:30. Medical registrar review if any concerns. Send electronic referral and notify the endoscopy unit coordinator on ext or before 10:30. Send electronic referral and discuss with endoscopy Unit coordinator on ext or at 08:30 Mon morning. Medical registrar review if any concerns. Unstable Patients GBS >5 Attend endoscopy unit and discuss with coordinator and endoscopist. Registrar or consultant to discuss with the endoscopist on call. Registrar or consultant to discuss with the endoscopist on call. Registrar or consultant to discuss with the endoscopist on call. 4.5 Emergency Endoscopy in Theatres (also see table 2) Unstable patients with GBS >5 (high risk bleed) presenting 5pm 9am weekdays and 9am-9am weekend days should be discussed with the endoscopist on call to consider emergency endoscopy in theatres The team responsible for the overall care of the patient should liaise with the theatre coordinator to add the case to the emergency list The team responsible for the overall care of the patient should liaise with the on-call anaesthetist on to enable them to support the patient during emergency endoscopy The team responsible for the overall care of patients with suspected acute non-variceal UGIB should liaise with the surgical registrar on call to enable appropriate surgical support The team responsible for the overall care of the patient should ensure the patient has received appropriate resuscitation prior to transfer to theatre. Page 8 of 14
9 4.5.6 Establish a clear plan for action to be taken in the event of uncontrolled GI haemorrhage prior to transfer to theatre Establish the ward to which the patient will be discharged to following the procedure prior to transfer to theatre The team responsible for the patient must make sure that a team member is available to accompany the patient to theatre and provide a handover. In situations when this is not possible, such as dealing with another emergency, the team must ensure an adequate handover to the anaesthetist and surgical team on call. 4.6 Management of Non-variceal UGIB One of the following methods should be used if endoscopic therapy is required; -mechanical method (clips) with or without adrenaline injection -thermal coagulation (heater probe) with adrenaline injection -fibrin or thrombin with adrenaline injection -Hemospray or equivalent may be used if the above modes of therapy are ineffective or cannot be applied Adrenaline monotherapy should not be used If endoscopic therapy is applied, patients should receive a stat intravenous dose of Omeprazole 80mg followed by 8mg per hour intravenous infusion for 72 hours Repeat endoscopy within 24 hours should be arranged if initial endoscopic therapy was suboptimal H. pylori status should be assessed in all patients with peptic ulceration Gastric ulcer healing should be confirmed by repeat gastroscopy in 6 to 8 weeks. The responsibility for booking this procedure lies with the team responsible for inpatient care Patients who re-bleed after endoscopic treatment should be referred urgently for surgery. Page 9 of 14
10 4.6.8 Interventional radiology is not immediately available at Salford Royal Hospital. Registrar or consultant referral for transfer to a centre where interventional radiology is available should be considered in patients who re-bleed after endoscopic treatment and in whom surgical management is considered inappropriate by the surgical on-call consultant. 4.7 Management of Variceal UGIB Band ligation should be used to control oesophageal variceal bleeding Balloon tamponade may be required if initial therapy is unsuccessful. This should be used as a bridge to definitive haemostasis either by repeat endoscopy (within 12 hours) or referral to a centre where transjugular intrahepatic portasystemic shunt (TIPSS) is available Terlipressin and antibiotics should be given to patients following endoscopic band ligation for oesophageal varices Bleeding gastric varices, or gastric varices with stigmata of recent bleeding should be treated with N-butyl-2-cyanoacrylate (fast acting adhesive sold for household use under trade name Super Glue ) injection as per protocol. Glue injection should only take place in a setting where appropriately trained endoscopy assistants are available. Page 10 of 14
11 Flow Diagram for Management of Acute Non-variceal UGIB RESUSCITATION RISK ASSESSMEMT BLATCHFORD = 0 Stable Patient BLATCHFORD 1 Stable Patient BLATCHFORD 5 Unstable Patient CONSIDER DISCHARGE WITH OUTPATIENT ENDOSCOPY INPATIENT ENDOSCOPY WITHIN 24 HRS ENDOSCOPY IMMEDIATELY AFTER RESUSCITATION SURGICAL OPINION REBLEED HAEMOSTASIS ACHIEVED REFER URGENTLY FOR SURGERY MANAGE ON EAU OR GASTROENTEROLOGY WARD IF SURGERY CONSIDERED INAPPROPRIATE +/- PPI BOLUS FOLLOWED BY 72HR INFUSION +/- H. PYLORI ERADICATION REFER FOR INTERVENTIONAL RADIOLOGY OR MANAGE CONSERVATIVELY Page 11 of 14
12 Flow Diagram for Management of Acute Variceal UGIB RESUSCITATION RISK ASSESSMEMT TERLIPRESSIN + ANTIBIOTICS BLATCHFORD 1 Stable Patient BLATCHFORD 5 Unstable Patient INPATIENT ENDOSCOPIC VARICEAL BANDING WITHIN 24 HRS ENDOSCOPIC VARICEAL BANDING IMMEDIATELY AFTER RESUSCITATION BLEEDING CONTINUES BALLOON TAMPONADE (SENGSTAKEN TUBE) HAEMOSTASIS ACHIEVED MANAGE ON EAU OR GASTROENTEROLOGY WARD + SECONDARY PROPHYLAXIS (ß BLOCKERS/ELECTIVE OUTPATIENT BANDING PROGRAMME) BLEEDING CONTINUES REFER FOR TIPSS OR MANAGE CONSERVATIVELY HAEMOSTASIS ACHIEVED MANAGE ON CRITICAL CARE UNIT CONSIDER REFERRAL FOR TIPSS OR REPEAT ENDOSCOPY + VARICEAL BANDING (SENGSTAKEN SHOULD BE REMOVED WITHIN 12HRS) Page 12 of 14
13 Standards (section number should follow on from the preceding section) BSG and NICE guidance June 2012 (Acute upper gastrointestinal bleeding: management, Issued: NICE clinical guidance 141 guidance.nice.org.uk/cg141 NHS). Explanation of terms & Definitions Upper GI Bleed Bleeding originating from the oesophagus, stomach or duodenum Varices Swollen blood vessels in stomach or oesophagus associated with cirrhosis of the liver References and Supporting Documents BSG and NICE guidance June 2012 (Acute upper gastrointestinal bleeding: management, Issued: NICE clinical guidance 141 guidance.nice.org.uk/cg141 NHS). Antibiotics Guidelines: Gastrointestinal Infections 144TD(C)25(D2) Massive Haemorrhage Protocol TC5(08) Roles and responsibilities 5.1 The first clinician to identify a patient as having an acute UGIB will request an endoscopy on Sunrise immediately. GBS should be documented on the request. 5.2 Within normal endoscopy unit hours, the coordinating nurse will review inpatient referrals for endoscopy and schedule patients with acute UGIB to have an endoscopy within the timeframes outlined by this SOP. 5.3 Outwith endoscopy unit working hours the on-call endoscopist should be contacted to discuss unstable patients with acute UGIB and GBS > A surgical assessment forms a routine part of management planning in unstable patients with suspected non-variceal acute UGIB. 5.5 Anaesthetic assessment is required in all patients where emergency endoscopy in theatres is planned. Page 13 of 14
14 Page 14 of 14
Gastrointestinal bleeding: the management of acute upper gastrointestinal bleeding
Gastrointestinal bleeding: the management of acute upper gastrointestinal bleeding NICE guideline Draft for consultation, December 2011 If you wish to comment on this version of the guideline, please be
More informationSIGN. Management of acute upper and lower gastrointestinal bleeding. September 2008. A national clinical guideline
SIGN Scottish Intercollegiate Guidelines Network Help us to improve SIGN guidelines - click here to complete our survey 105 Management of acute upper and lower gastrointestinal bleeding A national clinical
More informationManagement by the intensivist of gastrointestinal bleeding in adults and children
Osman et al. Annals of Intensive Care 2012, 2:46 REVIEW Open Access Management by the intensivist of gastrointestinal bleeding in adults and children David Osman 1*, Michel Djibré 2, Daniel Da Silva 3,
More informationBritish Society of Gastroenterology. St. Elsewhere's NHS Foundation Trust. National Comparative Audit of Blood Transfusion
British Society of Gastroenterology UK Com parat ive Audit of Upper Gast roint est inal Bleeding and t he Use of Blood December 2007 St. Elsewhere's NHS Foundation Trust National Comparative Audit of Blood
More informationOFFICE OF THE STATE CORONER FINDINGS OF INVESTIGATION
OFFICE OF THE STATE CORONER FINDINGS OF INVESTIGATION CITATION: TITLE OF COURT: JURISDICTION: Non-inquest findings into the death of Mr B Coroner s Court Brisbane DATE: 29 February 2016 FILE NO(s): 2015/1036
More informationGI Bleed. Steven Lichtenstein, D.O. Chief, Division of Gastroenterology Mercy Health System. Director, Endoscopy/GI Lab Mercy Fitzgerald Hospital
October 3, 2015 GI Bleed Steven Lichtenstein, D.O. Chief, Division of Gastroenterology Mercy Health System Director, Endoscopy/GI Lab Mercy Fitzgerald Hospital Clinical Associate Professor of Medicine
More informationEndoscopic Treatment of Bleeding Peptic Ulcers Panagiotis Katsinelos, MD, PhD
Endoscopic Treatment of Bleeding Peptic Ulcers Panagiotis Katsinelos, MD, PhD Department of Endoscopy and Motility Unit G. Gennimatas General Hospital of Thessaloniki Endoscopic diagnosis for UGI bleeding
More informationGI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics
GI Bleeding Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics Overview Because GI bleeding is internal, it is possible for a person to have GI bleeding without symptoms. Important to recognize
More informationNHS FORTH VALLEY Guidelines for use of high dose Intravenous Esomeprazole in Adults (Previously called the Hong Kong Protocol)
NHS FORTH VALLEY Guidelines for use of high dose Intravenous Esomeprazole in Adults (Previously called the Hong Kong Protocol) Date of First Issue 10/05/2010 Approved 16/06/2010 Current Issue Date 18/11/2015
More informationYou have been advised by your GP or hospital doctor to have an investigation known as a Gastroscopy.
Gastroscopy (OGD) The Procedure Explained You have been advised by your GP or hospital doctor to have an investigation known as a Gastroscopy. This procedure requires your formal consent. If you are unable
More informationClinical Guideline N/A. November 2013
State if the document is a Trust Policy/Procedure or a Clinical Guideline Clinical Guideline Document Title: Document Number 352 Version Number 1 Name and date and version number of previous document (if
More informationEnoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants
Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications
More informationDiagnosis and treatment of patients with gastrointestinal bleeding
Current Anaesthesia & Critical Care (2004) 15, 123 132 ARTICLE IN PRESS www.elsevier.com/locate/cacc MEDICAL Diagnosis and treatment of patients with gastrointestinal bleeding C. Meaden, A.J. Makin* UK
More informationManagement and Prevention of Upper GI Bleeding
Management and Prevention of Upper GI Bleeding By Jiwon Kim, Pharm.D., BCPS, FCSHP Reviewed by Clarence Chant, Pharm.D., FCSHP, FCCP, BCPS; and Steven E. Pass, Pharm.D., FCCP, FCCM, BCPS Learning Objectives
More informationInpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
More informationNew Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants
More informationThe digestive system. Medicine and technology. Normal structure and function Diagnostic methods Example diseases and therapies
The digestive system Medicine and technology Normal structure and function Diagnostic methods Example diseases and therapies The digestive system An overview (1) Oesophagus Liver (hepar) Biliary system
More informationGRASP-AF Coming to a PCT near you.
GRASP-AF Coming to a PCT near you. ADAS Anticoagulation dosing advisory service Blackpool Teaching Hospitals Trust Sean O'Brien; Anticoagulation Specialist BMS Grasp-AF and the implications on our Anticoagulation
More informationGastrointestinal Bleeding
Gastrointestinal Bleeding Introduction Gastrointestinal bleeding is a symptom of many diseases rather than a disease itself. A number of different conditions can cause gastrointestinal bleeding. Some causes
More information- Lessons from SHOT Haemorrhage cases
- Lessons from SHOT Haemorrhage cases Tony Davies Patient Blood Management Practitioner SHOT / NHSBT Patient Blood Management Team SHOT Annual Symposium 2013 For action by Trusts by April 2011 Decision
More informationRivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF
Leeds Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your
More informationAcute Abdominal Pain following Bariatric Surgery. Disclosure. Objectives 8/17/2015. I have nothing to disclose
Acute Abdominal Pain following Bariatric Surgery Kathy J. Morris, DNP, APRN, FNP C, FAANP University of Nebraska Medical Center College of Nursing Disclosure I have nothing to disclose Objectives Pathophysiology
More informationCare Pathway for the Administration of Intravenous Iron Sucrose (Venofer )
Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended
More informationTitle of Guideline. Thrombosis Pharmacist)
Title of Guideline Contact Name and Job Title (author) Guideline for patients receiving Rivaroxaban (Xarelto ) requiring Emergency Surgery or treatment for Haemorrhage Julian Holmes (Haemostasis and Thrombosis
More informationHaving a Gastroscopy (OGD)
Having a Gastroscopy (OGD) Endoscopy Department Page 16 Patient Information Having a Gastroscopy (OGD) You have been advised to have a gastroscopy to help find the cause of your symptoms. The test is sometimes
More information4.2 Spinal Cord Compression
4.2 Spinal Cord Compression AO Protocol Name: Metastatic Spinal Cord Compression (MSCC) AO Type: Type I (New Cancer), Type III (Cancer Complication) Author: ST Introduction: MSCC can cause irreversible
More informationCLINICAL GUIDELINE FOR MANAGEMENTS OF PATIENTS TAKING ANTICOAGULANTS IN ENDOSCOPY 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR MANAGEMENTS OF PATIENTS TAKING ANTICOAGULANTS IN ENDOSCOPY 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to assist decision making of whether anticoagulants
More informationGastroscopy the procedure explained
Gastroscopy the procedure explained Exceptional healthcare, personally delivered Introduction You have been advised by your GP or hospital doctor to have an investigation known as a gastroscopy (OGD).
More informationGloucestershire Hospitals
TRUST GUIDELINE In the case of hard copies of this policy the content can only be assured to be accurate on the date of issue marked on the document. The Policy framework requires that the policy is fully
More informationHERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below
Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications
More informationDrug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points
372 Gut 2001;49:372 379 Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points G M Hawkey, A T Cole, A S McIntyre, R G Long, C J Hawkey Division of Gastroenterology,
More informationImproving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting
Improving Appropriate Use of Proton Pump Inhibitors as Gastrointestinal Prophylaxis in the Hospital Setting DATE Educating for Quality Improvement & Patient Safety 1 The Team Division CS&E Participants
More informationRob Enns University of British Columbia, Vancouver. Grigorios Leontiadis McMaster University, Hamilton
Rob Enns University of British Columbia, Vancouver Grigorios Leontiadis McMaster University, Hamilton Accreditation This event has been approved as an accredited (Section1) group learning activity as defined
More informationAcute abdominal conditions Key Points
7 Acute abdominal conditions Key Points 7.1 ASSESSMENT AND DIAGNOSIS Referred abdominal pain Fore gut pain (stomach, duodenum, gall bladder) is referred to the upper abdomen Mid gut pain (small intestine,
More informationDabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF
Leeds Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your
More informationRivaroxaban for the treatment of Deep Vein Thrombosis in patients unsuitable for vitamin K antagonists
Rivaroxaban for the treatment of Deep Vein Thrombosis in patients unsuitable for vitamin K antagonists Traffic light classification- Amber 2 specialist initiation Information sheet for Primary Care Prescribers
More informationNHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS
NHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS Date of First Issue 01/12/ 2012 Approved 15/11/2012 Current Issue Date 29/10/2014 Review Date 29/10/2016
More informationCommunity health care services Alternatives to acute admission & Facilitated discharge options. Directory
Community health care services Alternatives to acute admission & Facilitated discharge options Directory Introduction The purpose of this directory is to provide primary and secondary health and social
More informationGastrointestinal bleeding
Gastrointestinal bleeding..is the reason in 2 % of all admissions to hospital 85.000 cases/year in the US. The incidence of urgent upper GI bleeding: 145/100.000 inhabitant/year in Hungary ( Nagy Gy. MBA
More informationThe University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery
Program Overview The University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery Weight Control and Metabolic Surgery Program The Weight Control and Metabolic
More informationOesophago-gastro duodenoscopy (OGD) the procedure explained. Your appointment details, information and consent form
Gastroscopy Oesophago-gastro duodenoscopy (OGD) the procedure explained Your appointment details, information and consent form Please bring this booklet with you For your information: your appointment
More informationWhat are peptic ulcers?
Information about Peptic ulcers www.corecharity.org.uk What are the symptoms? What are the causes? What are peptic ulcers? When should I consult a doctor? What will the doctor do? How should I treat peptic
More informationResident Medical Officer
MATER PRIVATE HOSPITAL JOB DESCRIPTION Resident Medical Officer 1.0 Job Title Resident Medical Officer Responsible for Admissions and House on-call cover 1.2 Report to Chief Resident Medical Officer 1.3
More informationBeaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject
Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: Guideline for administering Ferinject Guideline Number: 18 Guideline Version: a Developed By: Louise Kelly CNM 1 Renal Day Care
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationDabigatran (Pradaxa) Guidelines
Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without
More informationGuidelines for diagnosis and management of acute pulmonary embolism
Guidelines for diagnosis and management of acute pulmonary embolism By Dr. Ahmed Zaghloul M.D. Anesthesia & Critical Care 2014 Predisposing factors for VTE Predisposing factor Strong predisposing factors
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Omeprazol XXX 40 mg powder for solution for infusion omeprazole
PACKAGE LEAFLET: INFORMATION FOR THE USER Omeprazol XXX 40 mg powder for solution for infusion omeprazole Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You
More informationNational Clinical Programme in Surgery (NCPS) Care Pathway for the Management of Day Case Laparoscopic Cholecystectomy
National Clinical Programme in Surgery (NCPS) Care Pathway for the Management of Day Case Consultant Surgeon DRAFT VERSION 0.5 090415 Table of Contents 1.0 Purpose... 3 2.0 Scope... 3 3.0 Responsibility...
More informationRivaroxaban shared care guidelines for the prevention of stroke and embolism in adult patients with nonvalvular atrial fibrillation.
South West Essex Rivaroxaban Shared Care Guideline (SCG) Rivaroxaban shared care guidelines for the prevention of stroke and embolism in adult patients with nonvalvular atrial fibrillation. Introduction
More informationPRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT
PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON
More informationNorthumbria Healthcare NHS Foundation Trust Northumbria Endoscopy Service STUDENT NURSE AND NEW STAFF TRAINING AND INDUCTION PORTFOLIO FOR ENDOSCOPY
Northumbria Healthcare NHS Foundation Trust Northumbria Endoscopy Service STUDENT NURSE AND NEW STAFF TRAINING AND INDUCTION PORTFOLIO FOR ENDOSCOPY Northumbria Healthcare NHS Foundation Trust Surgical
More informationEarly Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi
Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the
More informationUpper Endoscopy (EGD)
Upper Endoscopy (EGD) Appointment Information: Patient Name: MRN: Physician Name: Location: _ For information on Directions, please visit: http://www.brighamandwomens.org/general/directions/directions.aspx
More informationObstetrics and Maternity
Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity Quick Reference Guide National Blood Authority, 2015. With the exception of any logos and registered trademarks, and where otherwise
More informationMCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013 Anticoagulants Anticoagulants are agents that prevent the formation of blood clots. Before we can talk about
More informationInformation Pathway. Myeloma tests and investigations. Paraprotein measurement
Information Pathway Myeloma UK Broughton House 31 Dunedin Street Edinburgh EH7 4JG Tel: + 44 (0) 131 557 3332 Fax: + 44 (0) 131 557 9785 Myeloma Infoline 0800 980 3332 www.myeloma.org.uk Charity No. SC
More informationPeptic Ulcer. Anatomy The stomach is a hollow organ. It is located in the upper abdomen, under the ribs.
Peptic Ulcer Introduction A peptic ulcer is a sore in the lining of your stomach or duodenum. The duodenum is the first part of your small intestine. Peptic ulcers may also develop in the esophagus. Nearly
More informationSurgery for oesophageal cancer
Surgery for oesophageal cancer This information is an extract from the booklet Understanding oesophageal cancer (cancer of the gullet). You may find the full booklet helpful. We can send you a free copy
More informationAASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
AASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, 1 Arun J. Sanyal, 2 Norman D. Grace, 3 William Carey, 4 and the
More informationChemoembolization for Patients with Pancreatic Neuroendocrine Tumours
Chemoembolization for Patients with Pancreatic Neuroendocrine Tumours What is this cancer? Pancreatic Endocrine Tumours are also called Pancreatic Neuroendocrine Tumours. This cancer is rare and it starts
More informationLaparoscopic Nephrectomy
Laparoscopic Nephrectomy Information for Patients This leaflet explains: What is a Nephrectomy?... 2 Why do I need a nephrectomy?... 3 What are the risks and side effects of laparoscopic nephrectomy?...
More informationRivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)
Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Amber Drug Level 2 Leeds We have started your patient on rivaroxaban for the treatment of provoked VTE (deep
More informationWhat can I eat? Peptic ulcers. What are peptic ulcers? What tests are needed? Will the ulcer come back? What causes a peptic ulcer?
In association with: INFORMATION ABOUT Peptic ulcers www.corecharity.org.uk What are peptic ulcers? What causes a peptic ulcer? How are NSAIDs and aspirin involved? How do I know if I ve got an ulcer?
More informationAcute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information)
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Alteplase (Tissue Plasminogen Activator (t-pa)), Activase in the Treatment
More informationArthroscopic rotator cuff repair
Arthroscopic rotator cuff repair The aim of this leaflet is to help answer some of the questions you may have about having an arthroscopic rotator cuff repair. It explains the benefits, risks and alternatives
More informationSession 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy
~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 3 of 4 Michael J. Sanfelippo, M.S. Technical Director, Coagulation Services Session 3 Topics Direct Thrombin Inhibitors:
More informationHAVING AN ENDOSCOPIC MUCOSAL RESECTION (EMR)
HAVING AN ENDOSCOPIC MUCOSAL RESECTION (EMR) Information Leaflet Your Health. Our Priority. Page 2 of 6 Having an EMR Previous tests have shown that you have a polyp in your large bowel (colon). Your doctor
More informationUK guidelines on the management of variceal haemorrhage in cirrhotic patients
UK guidelines on the management of variceal haemorrhage in cirrhotic patients 1 UK guidelines on the management of variceal haemorrhage in cirrhotic patients R Jalan, P C Hayes Department of Internal Medicine,
More informationUnless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version
Policy No: RM64 Version: 4.0 Name of Policy: Use of the National Early Warning Score System in Adult Patients Policy Effective From: 30/07/2015 Date Ratified 27/07/2015 Ratified Resuscitation and Deterioration
More informationHaving a Percutaneous Endoscopic Gastrostomy (PEG)
Having a Percutaneous Endoscopic Gastrostomy (PEG) Patient Information Author ID: L Dowle and N Prasad Leaflet Number: End 009 Name of Leaflet: Having a Percutaneous Endoscopic Gastrostomy (PEG) Date Produced:
More informationOesophageal Balloon Dilatation
Oesophageal Balloon Dilatation Patient Information Author ID: N Prasad Leaflet Number: End 008 Name of Leaflet: Oesophageal Balloon Dilation Date Produced: March 2014 Review Date: March 2016 Oesophageal
More informationRGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND
RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND Monitor patient on the ward to detect trends in vital signs and to manage accordingly To recognise deteriorating trends and request relevant medical/out
More informationPrescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients
Prescriber Guide 20mg Simply Protecting More Patients 15mg Simply Protecting More Patients 1 Dear Doctor, This prescriber guide was produced by Bayer Israel in cooperation with the Ministry of Health as
More informationBleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.
Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding may be spontaneous in the form of small haemorrhages into the
More informationReversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services
Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know Ronald Walsh, MD Chief Medical Officer Community Blood Services HEMOSTATIC PROCESS Initiation and formation of the platelet plug
More informationProtocol for the safe administration of iodinated contrast media in diagnostic radiology
Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol statement: This protocol applies to all staff within Radiology Departments at Heart of England NHS Foundation
More informationGASTRO-INTESTINAL BLEEDING
Introduction Site of Bleeding History Physical Examination Laboratory Tests Investigation Treatment References Introduction Gastrointestinal bleeding is an uncommon but important sign in paediatric patients.
More informationThe degree of liver inflammation or damage (grade) Presence and extent of fatty liver or other metabolic liver diseases
ilearning about your health Liver Biopsy www.cpmc.org/learning What is a Liver Biopsy? A liver biopsy is a procedure where a specially trained doctor (typically a hepatologist, radiologist, or gastroenterologist)
More informationNational Clinical Programmes
National Clinical Programmes Section 3 Background information on the National Clinical Programmes Mission, Vision and Objectives July 2011 V0. 6_ 4 th July, 2011 1 National Clinical Programmes: Mission
More informationOesophageal Stent Insertion
Oesophageal Stent Insertion Endoscopy Department Central Operations Group This leaflet has been designed to give you important information about your condition / procedure, and to answer some common queries
More informationPolicy & Procedure Manual Administration - Role and Expectations of the Most Responsible Physician (MRP)
The Scarborough Hospital Policy & Procedure Manual Administration - Role and Expectations of the Most Responsible Purpose To clarify and standardize the role of the Most Responsible at The Scarborough
More informationDuration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
More informationScreening for Varices and Prevention of Bleeding
Hepatitis C Online PDF created August 24, 2016, 3:30 am Screening for Varices and Prevention of Bleeding Module 3: Lesson 3: Contents: Management of Cirrhosis-Related Complications Screening for Varices
More informationAwareness of the inappropriate use of GI prophylaxis and its cost. Adverse effects of proton pump inhibitor
Understand the indication for stress ulcer/gi prophylaxis Awareness of the inappropriate use of GI prophylaxis and its cost Adverse effects of proton pump inhibitor A. 65yo w/ HTN and ESRD on HD p/w left
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
Diabetic ketoacidosis in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They
More informationEvaluation and Prognosis of Patients with Cirrhosis
Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded
More informationService Specification Template Department of Health, updated June 2015
Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st
More informationThe Blood Budget: how can we reduce costs and influence best practice? Sue Redfearn Blood Transfusion Manager Poole Hospital NHS Foundation Trust
The Blood Budget: how can we reduce costs and influence best practice? Sue Redfearn Blood Transfusion Manager Poole Hospital NHS Foundation Trust Poole Hospital vital statistics 680 beds 2011 (reduced
More informationNHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation
NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation Date of First Issue 06/06/2012 Approved 06/06/2012 Current Issue Date 29/10/2014 Review Date 29/10/2016 Version 1.4 EQIA Yes 01/06/2012
More informationunderstanding GI bleeding
understanding GI bleeding a consumer education brochure American College of Gastroenterology 4900B South 31st Street, Arlington, VA 22206 703-820-7400 www.acg.gi.org American College of Gastroenterology
More informationRivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Implementation of NICE TA 261 Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism Contents 1. Executive summary 2. Introduction
More informationOGD (Gastroscopy) Information for patients. Liver, Renal & Surgery. Confirming your identity
Liver, Renal & Surgery OGD (Gastroscopy) Information for patients This leaflet answers some of the questions you may have about having an OGD. It explains the risks and the benefits of the test and what
More informationHaving a kidney biopsy
Having a kidney biopsy Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm Introduction
More informationHemoClip: Guidelines & Atlas
HemoClip: Guidelines & Atlas Cases presented by: Dennis M. Jensen, MD, CURE DDRC, UCLA & VA Medical Centers, and David Geffen School of Medicine at UCLA 1 Epi Injection and Hemoclipping of Chronic Gastric
More informationUniveristy College Hospital. Subtotal and Total Gastrectomy. Gastrointestinal Services Division
Univeristy College Hospital Subtotal and Total Gastrectomy Gastrointestinal Services Division Author: Khaled Dawas, Consultant Upper Gastrointestinal Surgeon and Senior Lecturer First published: March
More informationEpidural Continuous Infusion. Patient information Leaflet
Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as
More informationHaving an Endoscopic Mucosal Resection (EMR)
Having an Endoscopic Mucosal Resection (EMR) Patient Information Author ID: N Prasad Leaflet Number: End 011 Name of Leaflet: Having an Endoscopic Mucosal Resection (EMR) Date Produced: March 2014 Review
More informationNational Patient Safety Goals Effective January 1, 2015
National Patient Safety Goals Goal 1 Nursing are enter ccreditation Program Improve the accuracy of patient and resident identification. NPSG.01.01.01 Use at least two patient or resident identifiers when
More information